Join international colleagues from 23 countries who already submitted their latest work for a chance to present at ICLE 2023. Shape the program of this year’s conference and be part of the future of lymphocyte engineering.

Discuss your work and find new collaborators that share your interests while giving your research a wide exposure not only for being under the spotlight in Munich, but also by having it published in the esteemed Human Gene Therapy Journal.

Submit by 3 April and note that this is your last opportunity to apply for an Oral presentation at ICLE 2023.

We look forward to receiving your abstract.